Target Pharmasolutions, Inc.

This study follows 15,000 adults and children (age 2+) with Crohn's disease, ulcerative colitis, or indeterminate colitis for up to 5 years. Researchers will collect data on how patients respond to treatments, side effects, and disease changes in everyday medical practice. The go…

This study follows 10,000 adults with hepatocellular carcinoma (a type of liver cancer) to see how the disease progresses and how doctors treat it in real-world settings. Researchers will collect information on treatments, side effects, and quality of life over time. The goal is …

This study is creating a large registry of 15,000 adults and children with inflammatory skin conditions like eczema, psoriasis, and vitiligo. Researchers will follow participants in regular clinics to see how well current and new treatments work and what side effects occur. The g…

This study follows up to 500,000 adults with chronic liver disease or cirrhosis to see how their condition changes over time and how well treatments work. Researchers will collect information from medical records and patient reports to improve care. No new treatments are being te…

This study was designed to observe people with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) to understand how the disease progresses and how well current treatments work. It planned to collect data from medical records and patient surveys, but was withdrawn be…

This study is observing up to 500,000 adults with chronic gastrointestinal diseases like Crohn's disease, ulcerative colitis, and eosinophilic GI disease. Researchers are collecting data from medical records and patient surveys to understand how these diseases progress and how we…